Details for New Drug Application (NDA): 078853
✉ Email this page to a colleague
The generic ingredient in DIVALPROEX SODIUM is divalproex sodium. There are eighteen drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.
Summary for 078853
| Tradename: | DIVALPROEX SODIUM |
| Applicant: | Orbion Pharms |
| Ingredient: | divalproex sodium |
| Patents: | 0 |
Pharmacology for NDA: 078853
| Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 078853
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DIVALPROEX SODIUM | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 078853 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8586 | 0615-8586-39 | 30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0615-8586-39) |
| DIVALPROEX SODIUM | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 078853 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8587 | 0615-8587-39 | 30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0615-8587-39) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 125MG VALPROIC ACID | ||||
| Approval Date: | Nov 25, 2008 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 250MG VALPROIC ACID | ||||
| Approval Date: | Nov 25, 2008 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 500MG VALPROIC ACID | ||||
| Approval Date: | Nov 25, 2008 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
